This meta-analysis shows that, compared with placebo, 12 months of intermittent or continuous montelukast was not associated with significant reduction in the frequency of wheezing episodes, USMA or need for OCS use. This may call into question the BTS  recommendations for the use montelukast in preschool wheeze.